Die chirurgische Therapie proximaler extrahepatischer Gallengangstumoren (Klatskin-Tumoren)

Zusammenfassung

Aufgrund der anatomischen Lage, der diffusen Wachstumstendenz und der extrem schlechten Prognose ohne Therapie stellen Klatskin-Tumoren eine besondere Herausforderung für Diagnostik und Therapie dar. Anders als bei sonstigen Tumoren des Gastrointestinaltraktes, für die klare diagnostische und stadienabhängige Therapieempfehlungen ausgesprochen werden konnten, existiert für die Therapie von Klatskin-Tumoren keine einheitliche Vorgehensweise. So zeigen die Langzeitdaten nach den lokal begrenzten Resektionsverfahren, wie der Hepatikusgabelresektion, eine inakzeptabel hohe Rate an R 1 / 2-Resektionen und frühe Tumorrezidive. Durch Erweiterung des Eingriffs um eine Leberresektion lassen sich sowohl die Rate an R 0-Resektionen als auch das Langzeitüberleben verbessern. Die Erweiterung der Leberresektion um den linksmedialen Sektor plus Pfortadergabelresektion ergibt die höchste Rate an formal kurativen Resektionen hilärer Gallengangskarzinome. Die Langzeitüberlebensdaten zur Lebertransplantation bei Klatskin-Tumoren haben bisher nicht überzeugt. Die viel versprechenden ersten Daten zur Kombination von neoadjuvanter Therapie und Lebertransplantation zeigen aber mögliche Perspektiven in der chirurgischen Therapie von Klatskin-Tumoren.

Abstract

Due to their anatomical position, the tendency of early infiltrative growth and their poor prognosis without treatment, klatskin tumors are challenging concerning diagnosis and therapy. In contrast to other tumors of the gastrointestinal tract, for which exact diagnostic and stage dependent therapeutic guidelines could be formulated, clear recommendations for klatskin tumors are missing. Thus, survival rates after local resection, e. g. resection of the bile duct bifurcation alone, show high rates of R 1 / 2 resection and early tumor recurrence. With an additional hepatic resection formally curative resections and long-term survival can be improved. Extended liver resections including the portal vein provide the highest rates of R 0 resections for hilar carcinomas of the extrahepatic bile duct. Survival rates after liver transplantation for klatskin tumors are not yet convincing. Promising first results have been reported for the combination of neoadjuvant treatment and liver transplantation and might show future perspectives for the treatment of klatskin tumors.

Schüsselwörter

Klatskin-Tumor - Gallengangskarzinom - Leberresektion - Lebertransplantation

Key words

Klatskin tumor - bile duct cancer - liver resection - liver transplantation

Literatur

• 1 Abdalla E K, Hicks M E, Vauthey J N. et al . Portal vein embolisation: rationale, technique and future perspective.  Br J Surg. 2001;  88 165-175
• 2 Alessiani M, Tzakis A, Todo S. et al . Assessment of five-year experience with abdominal organ cluster transplantation.  J Am Coll Surg. 1995;  180 1-9
• 3 Becker T, Lehner F, Bektas H. et al . Chirurgische Therapie hilärer Gallengangskarzinome (Klatskin-Tumoren).  Zentralbl Chir. 2003;  128 928-935
• 4 Bhuiya M R, Nimura Y, Kamiya J. et al . Clinicopathologic studies on perineural invasion of bile duct carcinomas.  Ann Surg. 1992;  215 244-349
• 5 Bismuth H, Corlette M B. Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver.  Surg Gynecol Obstet. 1975;  140 170-178
• 6 Bismuth H, Nakache R, Diamond T. Management strategies in resection for hilar cholangiocarcinoma.  Ann Surg. 1992;  215 31-38
• 7 Brown G, Meyer M. The hepatic ducts: a surgical approach for resection of tumors.  Aust NZ J Surg. 1954;  23 308-312
• 8 Busuttil R W, Tanaka K. The utility of marginal donors in liver transplantation.  Liver Transplant. 2003;  9 651-663
• 9 Casavilla F A, Marsh J W, Iwatsuki S. et al . Hepatic resection and transplantation for peripheral cholangiocarcinoma.  J Am Coll Surg. 1997;  185 429-436
• 10 Chalasani N, Baluyut A, Ismail A. et al . Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study.  Hepatology. 2000;  31 7-11
• 11 Chapman R W. Risk factors for biliary tract carcinogenesis.  Ann Oncol. 1999;  10 308-311
• 12 Cherqui D, Alon R, Piedbois P. et al . Combined liver transplantation and pancreatoduodenectomy for irresectable hilar bile duct carcinoma.  Br J Surg. 1995;  82 397-398
• 13 D'Angelica M, Jarnagin W R, Blumgardt L H. Resectable hilar cholangiocarcinoma: surgical treatment and long-term outcome.  Surg Today. 2004;  34 885-890
• 14 De Vreede J, Steeers J L, Burch P A. et al . Prolonged disease free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma.  Liver Transplant. 2000;  6 309-316
• 15 Ebata T, Nagino M, Kamiya J. et al . Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases.  Ann Surg. 2003;  238 720-727
• 16 Georgopoulos S K, Schwartz L H, Jarnagin W R. et al . Comparison of magnetic resonanz and endoscopic retrograde cholangiopancreatography in malignant pancreatobiliary obstruction.  Arch Surg. 1999;  134 1002-1007
• 17 Gerhards M F, van Gulik T M, Bosma A. et al . Long-term survival after liver resection of proximal bile duct carcinoma (klatskin tumors).  World J Surg. 1999;  23 91-96
• 18 Gerhards M F, Gulik T M, de Wit L T. et al . Evaluation of morbidity and mortality after resection for hilar cholangiocarcinoma: a single center experience.  Surgery. 2000;  127 395-404
• 19 Hatfield A RW, Tobias R, Terblanche J. et al . Preoperative external biliary drainage in obstructive jaundice: a prospective controlled clinical trial.  Lancet. 1982;  2 896-899
• 20 Heimbach J K, Gores G J, Haddock M G. et al . Liver transplantation for unresectable perihilar cholangiocarcinoma.  Semin Liver Dis. 2004;  24 201-217
• 21 Hemming A W, Reed A I, Fujita S. et al . Surgical management of hilar cholangiocarcinoma.  Ann Surg. 2005;  241 693-702
• 22 Iwatsuki S, Todo S, Marsh J W. et al . Treatment of hilar cholangiocarcinoma (klatskin tumors) with hepatic resection or transplantation.  J Am Coll Surg. 1998;  187 358-364
• 23 Jarnagin W R, Bowne W, Klimstra D S. et al . Papillary phenotype confers improved survival after resection of hilar cholangiocarcinoma.  Ann Surg. 2005;  241 703-712
• 24 Jarnagin W R, Fong Y, DeMatteo R P. et al . Staging, resectability and outcome in 225 patients with hilar cholangiocarcinoma.  Ann Surg. 2001;  234 507-517
• 25 Jeyarajah D R, Klintmalma G B. Is liver transplantation indicated for cholangiocarcinoma?.  Pancreatic Surg. 1998;  5 48-51
• 26 Jonas S, Kling N, Guckelberger O. et al . Orthotopic liver transplantation after extended bile duct resection as treatment of hilar cholangiocarcinoma. First long-term results.  Transpl Int. 1998;  187 358-364
• 27 Jonas S, Steinmüller T, Neuhaus P. Chirurgische Therapie von Leberhilustumoren.  Chirurg. 2001;  72 775-783
• 28 Kawasaki S, Imamura H, Kobayashi A. et al . Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolisation.  Ann Surg. 2003;  238 84-93
• 29 Khan S A, Davidson B R, Goldin R. et al . Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document.  Gut. 2002;  51 Suppl 6 VI 1-VI 9
• 30 Klatskin G. Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis.  Am J Med. 1965;  38 341-356
• 31 Knoefel W T, Prenzel K L, Peiper M. et al . Klatskin tumors and klatskin mimicking lesions of the biliary tree.  EJSO. 2003;  29 658-661
• 32 Lang H, Sotiropoulus G, Kaiser G. et al .The role of liver transplantation in the treatment of hilar cholangiocarcinoma. HPB 2005
• 33 Lang H, Sotiropoulos G C, Malago M. et al . Mesohepatectomy, caudate lobectomy and resection of hilar bifurcation with biliary reconstruction by 6 hepaticojejunostomies for klatskin tumor.  HepatoGastroenterology. 2003;  50 1327-1329
• 34 Launois B, Jamieson G G. Pylorus-preserving cluster operation.  Br J Surg. 1991;  78 1015
• 35 Launois B, Wemyss-Holden S, Maddern G J. Current and future trends in management and treatment of Klatsin tumour.  Int J Clin Oncol. 2002;  7 91-102
• 36 Lazaridis K N, Gores G J. Cholangiocarcinoma.  Gastroenterology. 2005;  128 1655-1667
• 37 Lopera J E, Soto J A, Munera F. Malignant hilar and perihilar biliary obstruction: use of MR cholangiography to define the extent of biliary ductal involvement and plan percutaneous interventions.  Radiology. 2001;  220 90-96
• 38 Lygidakis N J, Singh G, Safioleas M. et al . Changing trends in the management of klatskin tumor.  Hepatogastroenterology. 2004;  51 689-696
• 39 Madariaga J R, Iwatsuki S, Todo S. et al . Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases.  Ann Surg. 1998;  227 70-79
• 40 Meyer C G, Penn I, James L. et al . Liver transplantation for cholangiocarcinoma: results in 207 patients.  Transplantation. 2000;  69 1633-1637
• 41 Miyazaki M, Ito H, Nakagawa K. et al . Aggressive surgical approach to hilar cholangiocarcinoma: hepatic or local resection?.  Surgery. 1998;  123 131-136
• 42 Mizumoto R, Suzuki R. Surgical anatomy of the hepatic hilum with special reference to the caudate lobe.  World J Surg. 1988;  12 2-10
• 43 Nagino M, Kamiya J, Kanai M. et al . Right segmental portal vein embolisation for biliary tract carcinoma: technique and clinical utility.  Surgery. 2000;  127 155-160
• 44 Nagino M, Kamiya J, Toshiyuki A. et al . Anatomic right anatomic trisectionectomy extended right hepatectomy with caudate lobectomy for hilar cholangiocarcinoma.  Ann Surg. 2006;  243 28-32
• 45 Nagino M, Nimura Y, Kamiya J. et al . Segmental liver resection for hilar cholangiocarcinoma.  Hepatogastroenterology. 1998;  45 7-13
• 46 Neuhaus P, Jonas S, Bechstein W O. et al . Extended resections for hilar cholangiocarcinoma.  Ann Surg. 1999;  230 808-819
• 47 Neuhaus P, Jonas S, Settmacher U. et al . Surgical management of proximal bile duct cancer: extended right lobe resection increases resectability and radicality.  Langenbecks Arch Surg. 2003;  388 194-200
• 48 Neuhaus P, Jonas S. Surgery for hilar cholangiocarcinoma - the german experience.  J Hepatobiliary Pancreat Surg. 2000;  7 142-147
• 49 Nimura Y, Hayakawa N, Kamiya J. et al . Combined portal vein and liver resection for carcinoma of the biliary tract.  Br J Surg. 1991;  78 727-731
• 50 Nimura Y, Kamiya J, Kondo S. et al . Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience.  J HPB Surg. 2000;  7 155-162
• 51 Pichlmayer R, Weimann A, Klempnauer J. et al . Surgical treatment in proximal bile duct cancer: a single-center experience.  Ann Surg. 1996;  224 628
• 52 Pitt H A, Gomes A S, Lois J F. et al . Does preoperative percutaneous biliary drainage reduce operative risk or increase hospital cost.  Ann Surg. 1985;  201 545-553
• 53 Prall R T, Lindor K D, Wiesner R H. et al . Current therapies and clinical contoversies in the management of primary sclerosing cholangitis.  Curr Gastroenterol. 2000;  2 99-103
• 54 Rea D J, Heimbach J K, Rosen C K. et al . Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma.  Ann Surg. 2005;  242 451-461
• 55 Rumalla A, Baron T H, Leontovich O. et al . Improved diagnostic yield of endoscopic biliary brush cytology by digital image analysis.  Mayo Clin Proc. 2001;  76 29-33
• 56 Sewnath M E, Karsten T M, Prins M H. et al . A meta-analysis on the efficacy of preoperative biliary drainage for tumors causing obstructive jaundice.  Ann Surg. 2002;  236 17-27
• 57 Seyama Y, Kubota K, Sano K. et al . Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate.  Ann Surg. 2003;  238 73-83
• 58 Shaib Y H, El-Serag H B. The epidemiology of cholangiocarcinoma.  Semin Liver Dis. 2004;  24 115-125
• 59 Shimoda M, Farmer D G, Colquhoun S D. et al . Liver transplantation for cholangiocellular carcinoma: analysis of a single-center experience and review of the literature.  Liver Transplant. 2001;  7 1023-1033
• 60 Sotiropoulos G, Lang H, Niebel W. et al . 10 years tumor-free survival after intraoperative radiation therapy and secondary liver transplantation for hilar cholangiocarcinoma.  Transplantation. 2004;  77 1625
• 61 Tannapfel A, Sommerer F, Benicke M. et al . Genetic and epigenetic alterations of the INK 4 a-ARF pathway in cholangiocarcinoma.  J Pathol. 2002;  197 624-631
• 62 Tannapfel A, Wittekind C. Anatomy and pathology of intrahepatic and extrahepatic bile duct tumors.  Pathologe. 2001;  22 114-123
• 63 Tannapfel A, Wittekind C. Gallenblasen- und Gallengangskarzinom.  Internist. 2004;  45 33-41
• 64 Todoroki T, Kawamoto T, Koike N. et al . Radical resection of hilar bile duct carcinoma and predictors of survival.  Br J Surg. 2000;  87 306
• 65 Todoroki T. Radiotherapy as a component of multidisciplinary treatment of bile duct cancer: a surgeons perspective.  J Hepatobiliary Pancreat Surg. 2001;  8 130-136
• 66 Wall W J. Liver transplantation for hepatic and biliary malignancy.  Semin Liver Dis. 2000;  20 425-436
• 67 Zheng S S, Shi Q F, Liang T B. et al . Orthotopic liver transplantation for patients with klatskin tumor.  Hepatobiliary Pancreat Dis Int. 2005;  4 28-31